Guetter, C. R., Badreg, A. M., Martinez, C., Moura, D. L., Espinoza, E. A., Krause, F. P., Vismara, L., Godoy, L. C., Serrano, M. L., Sampaio, P. H. M. de A., Batista, R. S., & Illigens, B. M.-W. (2018). Monoclonal antibody against CGRP (TEV-48125) for preventive treatment of episodic cluster headache: a phase II randomized clinical trial protocol. Principles and Practice of Clinical Research, 4(1), 14–20. Retrieved from https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/53